Copyright
©The Author(s) 2025.
World J Exp Med. Jun 20, 2025; 15(2): 104328
Published online Jun 20, 2025. doi: 10.5493/wjem.v15.i2.104328
Published online Jun 20, 2025. doi: 10.5493/wjem.v15.i2.104328
Table 6 The effects of some antiepileptic drugs on the nutritional status of individuals with epilepsy
Drug class/drug | Nutrient affected | Effect on nutrient | Potential side effects and consequences | Recommendations |
Enzyme-inducing antiepileptic drugs | ||||
Phenytoin (Dilantin) | B1, B2, B3, B6, B12, Biotin, Folic Acid, K, Calcium, Vitamin D | Decreased absorption and metabolism, increased excretion | Nerve damage, fatigue, skin problems, anemia, developmental problems | Supplementation with affected vitamins, calcium and vitamin D, monitoring bone density |
Carbamazepine (Tegretol), Oxcarbazepine (Trileptal) | B1, B2, B3, B6, B12, folic acid, calcium, Vitamin D | Decreased absorption and metabolism, increased excretion | Like phenytoin | Similar recommendations as phenytoin |
Phenobarbital (Luminal) | B1, B2, B3, B6, B12, Folic Acid, Calcium, Vitamin D | Increased metabolism, decreased absorption | Like phenytoin, it may also cause drowsiness and cognitive problems | Similar recommendations as phenytoin, with additional monitoring for cognitive function |
Non-enzyme-inducing antiepileptic drugs | ||||
Levetiracetam (Keppra) | B12 | Decreased absorption | Anemia, nerve damage, generally well-tolerated, limited impact on nutrition | Supplementation with B12 |
Lamotrigine (Lamictal) | Bone metabolism | Potential impairment | Bone loss, osteoporosis | Calcium and vitamin D supplementation, monitoring bone density |
Topiramate (Topamax) | Weight, Glucose metabolism | Potential increase or decrease, possible impairment | Weight gain or loss, diabetes, altered taste perception | Dietary adjustments, monitoring weight and blood sugar |
Valproic acid (Depakote) | Weight, lipid metabolism | Potential increase | Increased risk of weight gain, altered lipid metabolism | Dietary adjustments, monitoring weight |
Gabapentin | Weight | Potential increase | Minimal impact on nutrition, some reports of weight gain | Dietary adjustments, monitoring weight |
Pregabalin | Weight, appetite | Potential increase | Weight gain, potential alterations in appetite | Dietary adjustments, monitoring weight |
- Citation: Al-Beltagi M, Saeed NK, Bediwy AS, Elbeltagi R. Unraveling the nutritional challenges in epilepsy: Risks, deficiencies, and management strategies: A systematic review. World J Exp Med 2025; 15(2): 104328
- URL: https://www.wjgnet.com/2220-315x/full/v15/i2/104328.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i2.104328